Moussa Youdim#
| Membership Number: | 7219 |
| Membership type: | ORDINARY |
| Section: | BASIC AND CLINICAL TRANSLATIONAL SCIENCES |
| Elected: | 2025 |
| Main Country of Residence: | ISRAEL |
| Homepage(s): | http://Youdim.com |
Present and Previous Positions
- 2008 - present Distinguished Scientific Professor, World Central Yonsei University, Seoul, South Korea
- 2008 - 2010 Distinguished Chair Professor, Department of Applied Biology and Modern Chinese Medicine, PolyTechnic University, Hong Kong
- 2009 Professor Emeritus, Technion-Rappaport Family Faculty of Medicine
- 1996 - 2009 Director of USA National Parkinson Foundation Center of Excellence, Technion-Rappaport Faculty of Medicine
- 1996 - 2009 Director of Eve Topf Neurodegenerative Diseases Center of Excellence for Teaching and Research, Technion-Faculty of Medicine, Technion-Rappaport Family Faculty of Medicine
- 1992 - 1994 Visiting Professor of Pharmacology, University of Florence, Florence, Italy
- 1984 - 1991 Professor of Pharmacology, Uniformed Armed Forces University, Washington DC, USA
- 1984 - 2009 Finkelstein Professor of Life Sciences, Faculty of Medicine, Technion lsrael Institute of Technology, Haifa, Israel
- 1983 - 1997 Professor of Biomedical Engineering, Department of Biomedical Engineering, Technion lsrael institute of Technology, Haifa, Israel
- 1976 - 1994 Chairman of Pharmacology, Faculty of Medicine, Technion lsrael Institute of Technology, Haifa, Israel
- 1977 - 2009 Professor of Pharmacology, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
- 1973 - 1977 M.R.C. Clinical Pharmacology Unit and University Department of Clinical Pharmacology and member of Faculty of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford, England
- 1972 - 1973 Wellcome Fellow, Unit de la Neurpharmacologie et Biochemique, College de France, 11 Place Marcelin Berthelot, Paris, France
- 1966 - 1972 Senior Research Associate, Postgraduate Medical School, University of London, London, England
Fields of Scholarship
- Parkinson's disease
- Multi target s drugs possessing neuroprotective and neurorestorative activities.
- Development of monoamine oxidase B inhibitors as anti Parkinson drugs, selegiline, Azilect
- Iron dysregulation in brain function
- Neurodegenerative diseases
- Molecular biology
- Drug development
- Alzheimer's disease
Honours and Awards
- 1974 Anna-Monika Prize in the field of neurobiology and the treatment of depressive disorders (Basel, Switzerland)
- 1974 British Migraine Association Special Gold Medal (London, England)
- 1978 The Homayoon (Royal) Medal (Teheran, Iran)
- 1980 Israel National Psychobiology Center Research Achievement Prize (Jerusalem, Israel)
- 1986 Michael Landau Research Prize (Tel Aviv, Israel)
- 1990 Senator Burda International Prize for Parkinson’s Disease (Vienna, Austria)
- 1991 Claudius Galenus Gold Medal Prize for Parkinson Disease, l-Deprenyl (selegiline) Drug of the Year (Berlin, Germany)
- 1991 Deutscher Neuropharmakologie (AGNP) Prize (Nurenburg, Germany)
- 1991 Eli Lilly Prize for Neuropsychopharmacology (Indianapolis, USA)
- 1993 The New England Prize for Excellence In Science (Boston, USA)
- 1991 - 1998 Fogarty International Scholar In Residence at Fogarty Center For Advanced Study In Human Health NIH, NIDDK and NIMH (Bethesda, USA)
- 1994 Henning Anderson Prize (Stockholm, Sweden)
- 1995 Hershel Rich Innovation Prize, Technion (Haifa, Israel)
- 1997 “Honoree Causa” Honorary Doctor of Philosophy. Semmelweiss University Medical School (Budapest, Hungary)
- 2000 Hershel Rich Innovation Prize, Technion, (Haifa, Israel)
- 2006 Herschel Rich Innovation Prize discovery of TVP-1022 a cardioprotective drug. Technion (Haifa, Israel)
- 2006 Henry Taub Prize for Excellence in Research, Technion, (Haifa, Israel)., Hi disease With Neurorestorative with drugs Mount Sinai School of Medicine, (New York, USA)
- 2007 Hirotaro Narabayashi Lecture. 17th International Congress of Parkinson’s Disease, (Amsterdam, Holland)
- 2007 World Federation of Neurology Award for Contribution to Parkinson’s Disease, 17th International Congress of Parkinson’s Disease, (Amsterdam, Holland)
- 2008 Distinguished Honorary Professor, University of Hong Hong, Hong Kong
- 2008 - 2010 Distinguished Chair Professor, PolyTechnic University of Hong Kong University, (Hong Kong, China)
- 2008 - 2009 Distinguished Honorary Professor, Department of Anatomy, Hong Kong University Hong Kong
- 2009 - 2014 Distinguished Scientific Professor of Neurobiology, Yonsei World Central University Department of Neuroibology, (Seoul, South Korea)
- 2010 European College Neuropsychopharmacology(ECNP) Life Time Achievement Neuropsychopharmacology Prize, (Amsterdam, Netherland)
- 2010 Elected Member of Leopoldina German Academy of Sciences (Halle, Germany)
- 2010 - present Distinguished Honorary Professor, Shanghai Rugin Univeristy Medical School, Shanghai, China
- 2010 - present Distinguished Honorary Professor, Materica Medica of Chinese Academy of Sciences Shanghai University of Traditional Chinese Medicine, Shanghai, China
- 2011 EMET Prize for Brain Sciences, (Jerusalem, Israel)
- 2011 Elected A Fellow of American College of Neuropsychopharmacology, USA
- 2012 Giant Pioneer of Catecholamine Research Prize, 10th International Congress of Catecholamines, (Asilomar, USA)
- 2012 CINP (International College of Neuropsychopharmacology) Pioneering Neuropsychopharmacology Prize, (Stockholm, Sweden)
- 2012 The Arvid Carlsson Medal, (Stockholm, Sweden)
- 2013 Elected Honorary Member of Israel Society for Neuroscience
- 2022 The Israel Prize In life Sciences, (Jerusalem, Israel)
- 2023 The Maimonides Award, Rambam Hospital, (Haifa, Israel)
- 2024 The Tel Aviv University Aufzien Center and Israel Parkinson Association Parkinson Prize, (Tel Aviv, Israel)
- 2025 Sir Henry J Wellcome Gold Medal, British Pharmacology Society for Pharmacology
